CASE REPORT
Year : 2022 | Volume
: 32 | Issue : 3 | Page : 168--171
Aortic biological prosthetic valve dysfunction secondary to endocarditis: Is percutaneous valve-in-valve an option?
Bottaro Giuseppe, Wanda Deste, Paolo Zappulla, Giulia Passaniti, Marco Barbanti, Enrico Criscione, Carmelo Sgroi, Corrado Tamburino
Division of Cardiology, A.O.U. Policlinico “G. Rodolico - San Marco”, Catania, Italy
Correspondence Address:
Paolo Zappulla
Division of Cardiology, A.O.U. Policlinico “G. Rodolico - San Marco”, Via Santa Sofia N 78, Catania
Italy
We present the case of a 69-year-old man with an aortic biological prosthetic valve. In May 2019, the patient experienced increasing dyspnea and fatigue: A diagnosis of prosthetic aortic valve dysfunction was made, leading to severe valvular insufficiency. The dysfunction of the prosthetic valve seemed to be linked to a previous infective endocarditis: after ruling out active endocarditis, the patient was treated with an off-label valve-in-valve transcatheter aortic valve implantation.
How to cite this article:
Giuseppe B, Deste W, Zappulla P, Passaniti G, Barbanti M, Criscione E, Sgroi C, Tamburino C. Aortic biological prosthetic valve dysfunction secondary to endocarditis: Is percutaneous valve-in-valve an option?.J Cardiovasc Echography 2022;32:168-171
|
How to cite this URL:
Giuseppe B, Deste W, Zappulla P, Passaniti G, Barbanti M, Criscione E, Sgroi C, Tamburino C. Aortic biological prosthetic valve dysfunction secondary to endocarditis: Is percutaneous valve-in-valve an option?. J Cardiovasc Echography [serial online] 2022 [cited 2023 Jan 31 ];32:168-171
Available from: https://www.jcecho.org/article.asp?issn=2211-4122;year=2022;volume=32;issue=3;spage=168;epage=171;aulast=Giuseppe;type=0 |
|
|
|
